Abstract

Background: Janus kinase (JAK) inhibitors represent a novel therapeutic class for treatment of inflammatory bowel disease.

Tags

Adverse Effects, Anti-Inflammatory Agents, Drug Therapy, IBD, Inflammatory Bowel Disease, Janus kinase inhibitors, therapeutic use, Treatment Outcome

Read More